AAAAAA

   
Results: 1-8 |
Results: 8
ANTIRETROVIRAL THERAPY IN SUB-SAHARAN AFRICA
Authors: MULLER O CORRAH T KATABIRA E PLUMMER F MABEY D
Citation: O. Muller et al., ANTIRETROVIRAL THERAPY IN SUB-SAHARAN AFRICA, Lancet, 351(9095), 1998, pp. 68-68
RISK-FACTORS FOR KAPOSIS-SARCOMA (KS) IN HIV-SEROPOSITIVE SUBJECTS INUGANDA
Authors: ZIEGLER J NEWTON R KATANGOLEMBIDDE E MBULATAIYE S DECOCK K WABINGA H KATABIRA E JAFFE H PARKIN DM REEVES G BERAL V
Citation: J. Ziegler et al., RISK-FACTORS FOR KAPOSIS-SARCOMA (KS) IN HIV-SEROPOSITIVE SUBJECTS INUGANDA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 30-30
PARTICIPATORY EVALUATION OF COUNSELING, MEDICAL AND SOCIAL-SERVICES OF THE AIDS-SUPPORT-ORGANIZATION (TASO) IN UGANDA
Authors: KALEEBA N KALIBALA S KASEJE M SSEBBANJA P ANDERSON S VANPRAAG E TEMBO G KATABIRA E
Citation: N. Kaleeba et al., PARTICIPATORY EVALUATION OF COUNSELING, MEDICAL AND SOCIAL-SERVICES OF THE AIDS-SUPPORT-ORGANIZATION (TASO) IN UGANDA, AIDS care, 9(1), 1997, pp. 13-26
RISK-FACTORS FOR KAPOSIS-SARCOMA IN HIV-POSITIVE SUBJECTS IN UGANDA
Authors: ZIEGLER JL NEWTON R KATONGOLEMBIDDE E MBULATAIYE S DECOCK K WABINGA H MUGERWA J KATABIRA E JAFFE H PARKIN DM REEVES G WEISS R BERAL V
Citation: Jl. Ziegler et al., RISK-FACTORS FOR KAPOSIS-SARCOMA IN HIV-POSITIVE SUBJECTS IN UGANDA, AIDS, 11(13), 1997, pp. 1619-1626
KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS AND KAPOSIS-SARCOMA IN AFRICA
Authors: CHANG YA ZIEGLER J WABINGA H KATANGOLEMBIDDE E BOSHOFF C SCHULZ T WHITBY D MADDALENA D JAFFE HW WEISS RA MOORE PS MUGERWA JW KATABIRA E MWIDU S BERAL V NEWTON R PARKIN M DECOCK K
Citation: Ya. Chang et al., KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS AND KAPOSIS-SARCOMA IN AFRICA, Archives of internal medicine, 156(2), 1996, pp. 202-204
HUMAN HERPESVIRUS-LIKE NUCLEIC-ACID IN VARIOUS FORMS OF KAPOSIS-SARCOMA
Authors: HUANG YQ LI JJ KAPLAN MH POIESZ B KATABIRA E ZHANG WC FEINER D FRIEDMANKIEN AE
Citation: Yq. Huang et al., HUMAN HERPESVIRUS-LIKE NUCLEIC-ACID IN VARIOUS FORMS OF KAPOSIS-SARCOMA, Lancet, 345(8952), 1995, pp. 759-761
PEPTIDE SEROLOGY FOR ANALYSIS OF THE INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIATION IN THE HIV-1 V3 DOMAIN
Authors: JANSSON M WAHREN B ALBERT J SCARLATTI G FRANZEN L KATAAHA PK KATABIRA E MUBIRO F WIGZELL H ROSSI P
Citation: M. Jansson et al., PEPTIDE SEROLOGY FOR ANALYSIS OF THE INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIATION IN THE HIV-1 V3 DOMAIN, AIDS, 8(4), 1994, pp. 413-421
PROPOSED WORLD-HEALTH-ORGANIZATION STAGING SYSTEM FOR HIV-INFECTION AND DISEASE - PRELIMINARY TESTING BY AN INTERNATIONAL COLLABORATIVE CROSS-SECTIONAL STUDY
Authors: CAHN P COOPER DA TINDALL B REIBNEGGER G STEINER B WACHTER H ZANGERLE R COLEBUNDERS R CORTES E CAMERON DW GARBER G HOWLEYFOSS N MONTANER JSG SCHECHTER M MATHIESEN L PINDBORG JJ CHARMOT G COULAUD JP DETRUCHIS P FEGUEUX S LAFAIX C MALKIN JE MASLO C MATHERON S PRAZUCK T ROZENBAUM W BRODT H ALVAREZ M CANTALUPPI P ESPOSITO R LIZIOLI A GOTO H IKEGAMI N OKA S SHIMADA K SUGIYAMA K YOSHIOKA K ATTAS H MANDALIYA D WAWERU H MWANSAMBO P WIRIMA J DELEON SP LANGE JMA GONZALEZLAHOZ J NAJERAMORRNDO R LALLINGER G MBAGA I MWAKYUSA D PERENBOOM R RICHTER C KATABIRA E MUBIRU F MUGERWA R WEBER J CASTRO K MILLS J MOSS RA REDFIELD R ROYCE R SCHREGER L WAGNER K POKROVSKY V YURIN O BIANCO N DEIBIS L PEREZECHEVERRIA G ALMAVIVA M CERAVOLO C KALAMBAY K KAPITA B PICCIONI I WELO K BURTON A CHIN J FARLEY T HENNESSEY K KRISTOFFERSSON SP MAJ M MANN J OSMANOV S VONSONNENBURG F TAMASHIRO H
Citation: P. Cahn et al., PROPOSED WORLD-HEALTH-ORGANIZATION STAGING SYSTEM FOR HIV-INFECTION AND DISEASE - PRELIMINARY TESTING BY AN INTERNATIONAL COLLABORATIVE CROSS-SECTIONAL STUDY, AIDS, 7(5), 1993, pp. 711-718
Risultati: 1-8 |